QTRX
Earnings in 1 day · May 6, 2026 · After close
Signal
Leaning Bearish1
Price
1
Move-0.88%Quiet session
Volume
1
Volume0.6× avgNormal activity
Technical
1
RSIRSI 33Momentum negative
PRICE
Prev Close
3.40
Open
3.33
Day Range3.28 – 3.47
3.28
3.47
52W Range2.95 – 8.77
2.95
8.77
7% of range
VOLUME & SIZE
Avg Volume
797.7K
FUNDAMENTALS
P/E Ratio
-1.3x
Not profitable
EPS (TTM)
Div Yield
No dividend
Beta
1.96
High vol
Performance
1D
-0.88%
5D
+1.51%
1M
-6.39%
3M
-46.68%
6M
-35.32%
YTD
-47.01%
1Y
-42.00%
Best: 5D (+1.51%)Worst: YTD (-47.01%)
Quick Read
TrendInsufficient MA data
Momentum
BULLISH
revenue +2% YoY · 47% gross margin
Valuation
FAIR
P/E not available
Health
MODERATE
CR 2.8 · FCF negative
Bullish
Key MetricsTTM
Market Cap$158.19M
Revenue TTM$138.73M
Net Income TTM-$107.15M
Free Cash Flow-$79.85M
Gross Margin46.6%
Net Margin-77.2%
Operating Margin-89.9%
Return on Equity-35.2%
Return on Assets-25.6%
Debt / Equity0.13
Current Ratio2.84
EPS TTM$-2.29

Intelligence analysis not yet available for this stock. Full AI-powered analysis may be available on the intelligence page.

Health Radar
2 strong4 concern
36/100
Liquidity
2.84Strong
Leverage
0.13Strong
Coverage
0.0xConcern
ROE
-35.2%Concern
ROIC
-33.8%Concern
Cash
$30MConcern
ANALYST COVERAGE10 analysts
BUY
+18.7%upside to target
Buy
550%
Hold
550%
5 Buy (50%)5 Hold (50%)0 Sell (0%)
Full report →
Stock Health
Composite Score
3 of 5 signals bullish
7/10
Technicals
RSI RangeRSI 33 — Bearish momentum
Volume
Volume FlowLean Accumulation
Fundamentals
Last EarningsMissed estimates
Analyst ConsensusBuy
LiquidityCurrent Ratio 2.84 — healthy liquidity
Upcoming Events
EEarnings ReportMay 6, 2026
Tomorrow
DEx-Dividend DateAug 3, 2026
In 90 days
PDividend PaymentAug 20, 2026
In 107 days
Technicals
Technical SetupBEARISH
Technicals →

Trend

DowntrendGolden Cross · 50D leads 200D by 18.7%

-46.2% vs SMA 50 · -36.1% vs SMA 200

Momentum

RSI33.2
Momentum fading
MACD-0.03
Below zero — bearish pulse · compressing
Market Position
Price Levels
52W High
$8.77+160.2%
EMA 50
$6.42+90.4%
EMA 200
$5.28+56.6%
Current
$3.37
52W Low
$2.95-12.5%
52-Week RangeNear 52-week low
$2.957th %ile$8.77
Squeeze SetupVolume-based
No Clear Setup

Volume distribution is neutral or leaning toward distribution. No compelling squeeze setup based on current money flow data.

20-Day Money Flow
Acc days:2
Dist days:2
Edge:Even
Volume Context
Avg Vol (50D)796K
Recent Vol (5D)
659K-17%

Based on volume distribution analysis. Direct short interest data (short float %, days to cover) is not available in current data sources.

Earnings & Analysts

ANALYST ESTIMATES

Consensus of 2 analysts
Analyst revisions:EPS↓ Revised DownRevenue↓ Revised Down

Analyst consensus estimates · Actuals replace estimates as reported

YearRevenue Est.Rev GthEPS Est.EPS GthRangeAnalysts
FY2025
$133.2M
$132.9M$133.4M
-$2.27
±1%
Low2
FY2026(current)
$170.9M
$170.3M$171.4M
+28.3%-$1.42
±1%
Low2
FY2027
$187.8M
$186.3M$189.3M
+9.9%-$1.26
±1%
Low2
Range confidence:Tight (high)ModerateWide (low)
Earnings HistoryQTRX
Last 8Q
-8.5%avg beat
Beat 4 of 8 quartersMissed 4 Estimates falling
+16%
Q2'24
+7%
Q3'24
+8%
Q4'24
-11%
Q1'25
+23%
Q2'25
-15%
Q3'25
-57%
Q4'25
-41%
Q1'26
Beat
Miss
Estimate
Deeper color = bigger beat/miss
* Negative EPS shown at reduced height
Financials

INSTITUTIONAL OWNERSHIP

1
Trium Capital LLP
994K
2
Nuveen, LLC
72K
3
PEDDOCK CAPITAL ADVISORS, LLC
52K
4
Post Resch Tallon Group Inc.
13K
5
Police & Firemen's Retirement System of New Jersey
10K
6
Versant Capital Management, Inc
2K
7
Sterling Capital Management LLC
1K
8
BRYN MAWR TRUST Co
800
News & Activity

QTRX News

20 articles · 4h ago

About

Quanterix is a company that's digitizing biomarker analysis with the goal of advancing the science of precision health. The company's digital health solution, Simoa, has the potential to change the way in which healthcare is provided today by giving researchers the ability to closely examine the continuum from health to disease. Quanterix' technology is designed to enable much earlier disease detection, better prognoses and enhanced treatment methods to improve the quality of life and longevity of the population for generations to come. The technology is currently being used for research applications in several therapeutic areas, including oncology, neurology, cardiology, inflammation and infectious disease. The company was established in 2007 and is located in Billerica, Massachusetts.

Everett V. CunninghamPresident, Chief Executive Officer & Director
Laurie A. ChurchillSenior Vice President, General Counsel & Secretary
Naren BhatSenior Vice President of Corporate Development & Strategy
PeersHealth Care(7 companies)
Screen sector →
SymbolPriceDay %Mkt CapP/ERev GrwMarginELO
QTRX
$3.37-0.88%$158M+255.5%-7714.3%1500
$68.99+0.00%$13.4B1500
$91.17+0.00%$12.0B-4239.0%1500
$518.66+0.96%$11.9B-3008.0%1500
$223.70+8.31%$11.4B+6554.5%-2868.8%1500
$76.39+0.00%$10.7B52.9+2325815.3%-19.7%1500
$182.03+0.00%$10.6B1500
Sector avg+1.20%52.9+777541.8%-3570.0%1500